Olaparib(AZD2281)

inquiry

Cat No.

CEI-0329

Description

Olaparib(AZD2281) can inhibit PARP1 and PARP2 with IC50 of 5 nM and 1 nM.

Alias

KU-0059436

CAS_No

763113-22-0

Molecular Weight

434.469

Purity

>99%

Storage

2 years at -20centigrade Powder

Synonyms

KU-0059436

Targets

PARP1, PARP2

Molecular Formula

C24H23FN4O3

Chemical Name

4-(3-(1-(cyclopropanecarbonyl)piperazine-4-carbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one

Solubility

DMSO 87 mg/mL Water

In vitro

Olaparib(AZD2281, KU0059436) is a selective inhibitor, which can potently inhibit PARP-1 and PARP-2 enzymes with IC50 of 5 nM and 1 nM, respectively.Treatment of these cell lines with 11 different anticancer drugs or with gamma-irradiation showed that AZD2281, a novel and specific PARP inhibitor, caused the strongest differential growth inhibition of BRCA2-deficient versus BRCA2-proficient mammary tumor cells. Synergistic cytotoxicity of AZD2281 and cisplatin against BRCA2-deficient cells but not against BRCA2-proficient control cells.

In vivo

AZD2281 significantly decreased tumor growth and increased overall survival in mice bearing s.c. xenografts of ATM-deficient Granta-519 cells while producing only a modest effect on overall survival of mice bearing xenografts of the ATM-proficient cell line, Z138. Olaparib as maintenance treatment significantly improved progression-free survival among patients with platinum-sensitive, relapsed, high-grade serous ovarian cancer.

Name:

Email *

Phone:*

Company/Institution:

Country or Region:

Quantity:

Services & Products Interested *

Project Description:

Our Products Cannot Be Used As Medicines Directly For Personal Use.

Products

Online Inquiry